We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Molecular Assay Quantifies Epstein-Barr Viral Load

By LabMedica International staff writers
Posted on 09 Jan 2012
Accurate and highly sensitive tests are essential for the diagnosis of active Epstein-Barr virus (EBV) infection for the clinical management of individuals infected with the virus. More...


A calibrated quantitative real-time polymerase chain reaction (PCR) assay for the measurement of EBV DNA of both EBV-1 and 2 subtypes has been developed, combining the detection of the EBV DNA and a synthetic DNA calibrator in a multiplex PCR format.

Scientists at the San Raffaele Scientific Institute (Milan, Italy) developed a real time quantitative PCR assay and clinically validated the method. Several cohorts of individuals including patients with EBV-associated diseases obtained from different geographic areas were recruited and tested. The clinical sensitivity and specificity of the system were evaluated by testing 181 peripheral blood mononuclear cell (PBMCs) and plasma specimens obtained from 21 patients subjected to bone marrow transplantation, 70 HIV-seropositive subjects, and 23 healthy controls.

Optimization of the reactions was achieved by determining the concentrations of primers and probes, as well as the annealing temperature yielding the highest intensity of reporter fluorescent signal without a reduction in specificity or sensitivity. This was achieved using the Absolute qPCR ROX master mix (ABgene; Epsom, UK). The assay displays a wide dynamic range and a high degree of accuracy even in the presence of 1 μg of human genomic DNA. This assay measures with the same efficiency EBV DNA from strains prevalent in different geographic areas. Patients affected by EBV-associated posttransplant lymphoproliferative disorders had the highest frequency of EBV detection and the highest viral load. Persons infected with HIV had higher levels of EBV DNA load in PBMCs and a higher frequency of EBV plasma viremia compared to healthy controls.

The authors concluded that this new assay provides a reliable high-throughput method for the quantitation of EBV DNA in clinical samples. The calibrated real-time PCR technique will offer clinicians a fast and reliable method for establishing an etiologic link between EBV and human diseases, as well as to monitor the risk of developing EBV-associated malignancies and the efficacy of therapeutic approaches against EBV infection. The study was published in the December 2011 issue of the Journal of Virological Methods.

Related Links:

San Raffaele Scientific Institute
ABgene



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Clinical Chemistry System
P780
New
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: A diagnostic test can distinguish patients with head and neck squamous cell carcinoma who can be cured with surgery alone (Photo courtesy of University of Turku)

Novel Diagnostic Tool to Revolutionize Treatment Guidance of Head and Neck Cancer

Head and neck squamous cell carcinoma (HNSCC) is a solid tumor type commonly treated with surgery. However, there has been no clinically available method to determine which patients can be cured with surgery... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.